Filter results
You can narrow down the results using the filters
Action
- (-) Medicine suspension (354)
- Medical device cancellation (751)
- Complementary medicine cancellation (198)
- Medical device suspension (71)
- Revocation of a TGA issued Conformity Assessment Certificate (24)
- Medical device cancellation - certain devices within an entry (14)
- Registered medicine cancellation (12)
- Medical device cancellation - requested by the sponsor - certain devices within an entry (8)
Date of effect
Find out more about Cancellations and Suspensions.
Search
354 result(s) found, displaying 1 to 25
- Cancellation or suspensionTRUST HEARTBURN RELIEF EXTRA STRENGTH ranitidine (as hydrochloride) 300 mg tablet strip pack (Suspension from the ARTG under s.29D(1)(b))Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2023
- Cancellation or suspensionTRUST HEARTBURN RELIEF ranitidine (as hydrochloride) 150 mg tablet strip pack (Suspension from the ARTG under s.29D(1)(b))Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2023
- Cancellation or suspensionMEDIHEALTH RANITIDINE 150mg tablet blister pack (Suspension from the ARTG under s.29D(1)(b))Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2023
- Cancellation or suspensionMEDIHEALTH RANITIDINE COOL MINT COATED ranitidine 150mg tablet blister pack (Suspension from the ARTG under s.29D(1)(b))Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2023
- Cancellation or suspensionCOLES HEARTBURN & ACID INDIGESTION ranitidine 150 mg (as hydrochloride) tablet blister pack (Suspension from the ARTG under s.29D(1)(b))Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2023
- Cancellation or suspensionMEDI CHOICE HEARTBURN & ACID INDIGESTION ranitidine hydrochloride 167.5mg tablet blister pack (Suspension from the ARTG under s.29D(1)(b))Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2023
- Cancellation or suspensionMEDIX HEARTBURN & ACID INDIGESTION ranitidine hydrochloride 167.5 mg tablets blister pack (Suspension from the ARTG under s.29D(1)(b))Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2023
- Cancellation or suspensionMEDREICH RANITIDINE 150 MG TABLETS BP (as hydrochloride) blister pack (Suspension from the ARTG under s.29D(1)(b))Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2023
- Cancellation or suspensionMEDREICH RANITIDINE 300 MG TABLETS BP (as hydrochloride) blister pack (Suspension from the ARTG under s.29D(1)(b))Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2023
- Cancellation or suspensionCIP RANITIDINE 300 ranitidine (as hydrochloride) 300 mg tablet strip pack (Suspension from the ARTG under s.29D(1)(b))Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., 29/01/2023
- Cancellation or suspensionCIP RANITIDINE 150 ranitidine (as hydrochloride) 150 mg tablet strip pack (Suspension from the ARTG under s.29D(1)(b))Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2023
- Cancellation or suspensionCIPLA REFLUX RELIEF EXTRA STRENGTH ranitidine (as hydrochloride) 300mg tablet strip pack (Suspension from the ARTG under s.29D(1)(b))Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2023
- Cancellation or suspensionCIPLA REFLUX RELIEF ranitidine (as hydrochloride) 150mg tablet strip pack (Suspension from the ARTG under s.29D(1)(b))Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2023
- Cancellation or suspensionZOLISON FORTE 300mg ranitidine (as hydrochloride) film-coated tablet blister pack (Suspension from the ARTG under s.29D(1)(b))Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2023
- Cancellation or suspensionZOLISON 150mg ranitidine (as hydrochloride) tablet blister pack (Suspension from the ARTG under s.29D(1)(b))Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2023
- Cancellation or suspensionZANTAC DOUBLE STRENGTH ranitidine 300mg (as hydrochloride) tablet blister pack (Suspension from the ARTG under s.29D(1)(b))Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2023
- Cancellation or suspensionZANTAC ranitidine 150mg (as hydrochloride) tablet blister pack (OTC) (Suspension from the ARTG under s.29D(1)(b))Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2023
- Cancellation or suspensionZANTAC 75 ranitidine 75mg (as hydrochloride) tablet (Suspension from the ARTG under s.29D(1)(b))Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2023
- Cancellation or suspensionZANTAC ranitidine 150mg (as hydrochloride) tablet blister pack (Suspension from the ARTG under s.29D(1)(b))Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2023
- Cancellation or suspensionZANTAC ranitidine 300mg (as hydrochloride) tablet blister pack (Suspension from the ARTG under s.29D(1)(b))Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2023
- Cancellation or suspensionZANTAC ranitidine 300mg (as hydrochloride) effervescent tablet strip pack (Suspension from the ARTG under s.29D(1)(b))Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2023
- Cancellation or suspensionZANTAC ranitidine 150mg (as hydrochloride) effervescent tablet strip pack (Suspension from the ARTG under s.29D(1)(b))Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2023
- Cancellation or suspensionZANTAC ranitidine 300mg (as hydrochloride) effervescent tablet tube (Suspension from the ARTG under s.29D(1)(b))Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2023
- Cancellation or suspensionZANTAC ranitidine 150mg (as hydrochloride) effervescent tablet tube (Suspension from the ARTG under s.29D(1)(b))Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2023
- Cancellation or suspensionZANTAC ranitidine 150mg/10mL (as hydrochloride) oral liquid bottle (Suspension from the ARTG under s.29D(1)(b))Regulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2023